HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.
Clinical trial NCT00412022 · UNKNOWN
Trial details
- NCT number
- NCT00412022
- Sponsor
- National Cancer Institute, Naples
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2024-11-01
- Enrollment
- 1294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.